These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38669358)
1. Dose adjustment strategy of levetiracetam in pregnant patients with epilepsy: Case report and literature review. Liu R; Xiao L; Liu X; Xiao C Medicine (Baltimore); 2024 Apr; 103(17):e37977. PubMed ID: 38669358 [TBL] [Abstract][Full Text] [Related]
2. AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies. Thangaratinam S; Marlin N; Newton S; Weckesser A; Bagary M; Greenhill L; Rikunenko R; D'Amico M; Rogozińska E; Kelso A; Hard K; Coleman J; Moss N; Roberts T; Middleton L; Dodds J; Pullen A; Eldridge S; Pirie A; Denny E; McCorry D; Khan KS Health Technol Assess; 2018 May; 22(23):1-152. PubMed ID: 29737274 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring in pregnancy: Levetiracetam. Fallik N; Trakhtenbroit I; Fahoum F; Goldstein L Epilepsia; 2024 May; 65(5):1285-1293. PubMed ID: 38400747 [TBL] [Abstract][Full Text] [Related]
4. Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential. Serafini A; Gerard E; Genton P; Crespel A; Gelisse P CNS Drugs; 2019 Mar; 33(3):195-208. PubMed ID: 30747367 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic monitoring of antiepileptic drugs during pregnancy and in the postpartum period: is it useful? Adab N CNS Drugs; 2006; 20(10):791-800. PubMed ID: 16999450 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic Drug Monitoring of Antiepileptic Drugs in Women with Epilepsy Before, During, and After Pregnancy. Arfman IJ; Wammes-van der Heijden EA; Ter Horst PGJ; Lambrechts DA; Wegner I; Touw DJ Clin Pharmacokinet; 2020 Apr; 59(4):427-445. PubMed ID: 31912315 [TBL] [Abstract][Full Text] [Related]
7. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy. Reisinger TL; Newman M; Loring DW; Pennell PB; Meador KJ Epilepsy Behav; 2013 Oct; 29(1):13-8. PubMed ID: 23911354 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic Drug Monitoring of Levetiracetam in Different Trimesters of Pregnant Women with Epilepsy in a Tertiary Care Center: A Prospective Study. Kumaravel J; Sarma P; Suri V; Singh P; Prakash A; Medhi B Neurol India; 2024 Mar; 72(2):358-363. PubMed ID: 38691482 [TBL] [Abstract][Full Text] [Related]
9. Review on the relevance of therapeutic drug monitoring of levetiracetam. Sourbron J; Chan H; Wammes-van der Heijden EA; Klarenbeek P; Wijnen BFM; de Haan GJ; van der Kuy H; Evers S; Majoie M Seizure; 2018 Nov; 62():131-135. PubMed ID: 30237016 [TBL] [Abstract][Full Text] [Related]
10. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Weston J; Bromley R; Jackson CF; Adab N; Clayton-Smith J; Greenhalgh J; Hounsome J; McKay AJ; Tudur Smith C; Marson AG Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010224. PubMed ID: 27819746 [TBL] [Abstract][Full Text] [Related]
11. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952 [TBL] [Abstract][Full Text] [Related]
12. The effect of serum levetiracetam concentrations on therapeutic response and IL1-beta concentration in patients with epilepsy. Gulcebi MI; Kendirli T; Turgan ZA; Patsalos PN; Onat Yilmaz F Epilepsy Res; 2018 Dec; 148():17-22. PubMed ID: 30326332 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study. Liguori C; Izzi F; Manfredi N; D'Elia A; Mari L; Mercuri NB; Fabio P Epilepsy Behav; 2018 Mar; 80():173-176. PubMed ID: 29414548 [TBL] [Abstract][Full Text] [Related]
14. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. Veroniki AA; Cogo E; Rios P; Straus SE; Finkelstein Y; Kealey R; Reynen E; Soobiah C; Thavorn K; Hutton B; Hemmelgarn BR; Yazdi F; D'Souza J; MacDonald H; Tricco AC BMC Med; 2017 May; 15(1):95. PubMed ID: 28472982 [TBL] [Abstract][Full Text] [Related]
15. Effects of monitoring strategies on seizures in pregnant women on lamotrigine: a meta-analysis. Pirie DA; Al Wattar BH; Pirie AM; Houston V; Siddiqua A; Doug M; Bagary M; Greenhill L; Khan KS; McCorry D; Thangaratinam S Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():26-31. PubMed ID: 24211103 [TBL] [Abstract][Full Text] [Related]
16. Eslicarbazepine acetate as a replacement for levetiracetam in people with epilepsy developing behavioral adverse events. Jalihal V; Shankar R; Henley W; Parrett M; Tittensor P; McLean BN; Ahmed A; Sander JW Epilepsy Behav; 2018 Mar; 80():365-369. PubMed ID: 29415871 [TBL] [Abstract][Full Text] [Related]
17. Association of Levetiracetam Concentration With Seizure Frequency in Pregnant Women With Epilepsy. Schelhaas M; Wegner I; Edens M; Wammes-Van Der Heijden E; Touw D; Ter Horst P Neurology; 2023 Jan; 100(2):e172-e181. PubMed ID: 36257713 [TBL] [Abstract][Full Text] [Related]
19. Increased levetiracetam clearance associated with a breakthrough seizure in a pregnant patient receiving once/day extended-release levetiracetam. Garrity LC; Turner M; Standridge SM Pharmacotherapy; 2014 Jul; 34(7):e128-32. PubMed ID: 24807683 [TBL] [Abstract][Full Text] [Related]
20. [Pharmacological treatment of women with epilepsy before and during pregnancy]. Müffelmann B; Bien CG Nervenarzt; 2016 Oct; 87(10):1115-1126. PubMed ID: 27631817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]